Integra Lifesciences Holdings (FRA:IL3) Beginning Cash Position : €254 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Integra Lifesciences Holdings Beginning Cash Position?

Integra Lifesciences Holdings's Beginning Cash Position for the quarter that ended in Mar. 2024 was €254 Mil.

Integra Lifesciences Holdings's quarterly Beginning Cash Position declined from Sep. 2023 (€290 Mil) to Dec. 2023 (€251 Mil) but then increased from Dec. 2023 (€251 Mil) to Mar. 2024 (€254 Mil).

Integra Lifesciences Holdings's annual Beginning Cash Position increased from Dec. 2021 (€416 Mil) to Dec. 2022 (€485 Mil) but then declined from Dec. 2022 (€485 Mil) to Dec. 2023 (€419 Mil).

Integra Lifesciences Holdings Beginning Cash Position Historical Data

The historical data trend for Integra Lifesciences Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integra Lifesciences Holdings Beginning Cash Position Chart

Integra Lifesciences Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

124.95

163.50

416.10

484.70

418.76

Integra Lifesciences Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															426.52	283.70	289.71	251.01	254.29

Integra Lifesciences Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Integra Lifesciences Holdings Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Integra Lifesciences Holdings's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Integra Lifesciences Holdings (FRA:IL3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Integra Lifesciences Holdings Corp (FRA:IL3) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

IART:USA

Address

1100 Campus Road, Princeton, NJ, USA, 08540

Website

https://www.integralife.com

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Integra Lifesciences Holdings (FRA:IL3) Headlines

No Headlines